The Potential of SHAP and Machine Learning for Personalized Explanations of Influencing Factors in Myopic Treatment for Children

<i>Background and Objectives:</i> The rising prevalence of myopia is a significant global health concern. Atropine eye drops are commonly used to slow myopia progression in children, but their long-term use raises concern about intraocular pressure (IOP). This study uses SHapley Additive...

Full description

Saved in:
Bibliographic Details
Main Authors: Jun-Wei Chen, Hsin-An Chen, Tzu-Chi Liu, Tzu-En Wu, Chi-Jie Lu
Format: Article
Language:English
Published: MDPI AG 2024-12-01
Series:Medicina
Subjects:
Online Access:https://www.mdpi.com/1648-9144/61/1/16
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832588009683288064
author Jun-Wei Chen
Hsin-An Chen
Tzu-Chi Liu
Tzu-En Wu
Chi-Jie Lu
author_facet Jun-Wei Chen
Hsin-An Chen
Tzu-Chi Liu
Tzu-En Wu
Chi-Jie Lu
author_sort Jun-Wei Chen
collection DOAJ
description <i>Background and Objectives:</i> The rising prevalence of myopia is a significant global health concern. Atropine eye drops are commonly used to slow myopia progression in children, but their long-term use raises concern about intraocular pressure (IOP). This study uses SHapley Additive exPlanations (SHAP) to improve the interpretability of machine learning (ML) model predicting end IOP, offering clinicians explainable insights for personalized patient management. <i>Materials and Methods:</i> This retrospective study analyzed data from 1191 individual eyes of 639 boys and 552 girls with myopia treated with atropine. The average age of the whole group was 10.6 ± 2.5 years old. The refractive error of spherical equivalent (SE) in myopia degree was base SE at 2.63D and end SE at 3.12D. Data were collected from clinical records, including demographic information, IOP measurements, and atropine treatment details. The patients were divided into two subgroups based on a baseline IOP of 14 mmHg. ML models, including Lasso, CART, XGB, and RF, were developed to predict the end IOP value. Then, the best-performing model was further interpreted using SHAP values. The SHAP module created a personalized and dynamic graphic to illustrate how various factors (e.g., age, sex, cumulative duration, and dosage of atropine treatment) affect the end IOP. <i>Results</i>: RF showed the best performance, with superior error metrics in both subgroups. The interpretation of RF with SHAP revealed that age and the recruitment duration of atropine consistently influenced IOP across subgroups, while other variables had varying effects. SHAP values also offer insights, helping clinicians understand how different factors contribute to predicted IOP value in individual children. <i>Conclusions:</i> SHAP provides an alternative approach to understand the factors affecting IOP in children with myopia treated with atropine. Its enhanced interpretability helps clinicians make informed decisions, improving the safety and efficacy of myopia management. This study demonstrates the potential of combining SHAP with ML models for personalized care in ophthalmology.
format Article
id doaj-art-a6f68c3431244406975afbdae94bb0bd
institution Kabale University
issn 1010-660X
1648-9144
language English
publishDate 2024-12-01
publisher MDPI AG
record_format Article
series Medicina
spelling doaj-art-a6f68c3431244406975afbdae94bb0bd2025-01-24T13:40:15ZengMDPI AGMedicina1010-660X1648-91442024-12-016111610.3390/medicina61010016The Potential of SHAP and Machine Learning for Personalized Explanations of Influencing Factors in Myopic Treatment for ChildrenJun-Wei Chen0Hsin-An Chen1Tzu-Chi Liu2Tzu-En Wu3Chi-Jie Lu4School of Medicine, Chang Gung University, Taoyuan 333, TaiwanSchool of Medicine, Chang Gung University, Taoyuan 333, TaiwanGraduate Institute of Business Administration, Fu Jen Catholic University, New Taipei City 242, TaiwanSchool of Medicine, Fu Jen Catholic University, New Taipei City 242, TaiwanGraduate Institute of Business Administration, Fu Jen Catholic University, New Taipei City 242, Taiwan<i>Background and Objectives:</i> The rising prevalence of myopia is a significant global health concern. Atropine eye drops are commonly used to slow myopia progression in children, but their long-term use raises concern about intraocular pressure (IOP). This study uses SHapley Additive exPlanations (SHAP) to improve the interpretability of machine learning (ML) model predicting end IOP, offering clinicians explainable insights for personalized patient management. <i>Materials and Methods:</i> This retrospective study analyzed data from 1191 individual eyes of 639 boys and 552 girls with myopia treated with atropine. The average age of the whole group was 10.6 ± 2.5 years old. The refractive error of spherical equivalent (SE) in myopia degree was base SE at 2.63D and end SE at 3.12D. Data were collected from clinical records, including demographic information, IOP measurements, and atropine treatment details. The patients were divided into two subgroups based on a baseline IOP of 14 mmHg. ML models, including Lasso, CART, XGB, and RF, were developed to predict the end IOP value. Then, the best-performing model was further interpreted using SHAP values. The SHAP module created a personalized and dynamic graphic to illustrate how various factors (e.g., age, sex, cumulative duration, and dosage of atropine treatment) affect the end IOP. <i>Results</i>: RF showed the best performance, with superior error metrics in both subgroups. The interpretation of RF with SHAP revealed that age and the recruitment duration of atropine consistently influenced IOP across subgroups, while other variables had varying effects. SHAP values also offer insights, helping clinicians understand how different factors contribute to predicted IOP value in individual children. <i>Conclusions:</i> SHAP provides an alternative approach to understand the factors affecting IOP in children with myopia treated with atropine. Its enhanced interpretability helps clinicians make informed decisions, improving the safety and efficacy of myopia management. This study demonstrates the potential of combining SHAP with ML models for personalized care in ophthalmology.https://www.mdpi.com/1648-9144/61/1/16myopiaatropineintraocular pressuremachine learningSHAP value
spellingShingle Jun-Wei Chen
Hsin-An Chen
Tzu-Chi Liu
Tzu-En Wu
Chi-Jie Lu
The Potential of SHAP and Machine Learning for Personalized Explanations of Influencing Factors in Myopic Treatment for Children
Medicina
myopia
atropine
intraocular pressure
machine learning
SHAP value
title The Potential of SHAP and Machine Learning for Personalized Explanations of Influencing Factors in Myopic Treatment for Children
title_full The Potential of SHAP and Machine Learning for Personalized Explanations of Influencing Factors in Myopic Treatment for Children
title_fullStr The Potential of SHAP and Machine Learning for Personalized Explanations of Influencing Factors in Myopic Treatment for Children
title_full_unstemmed The Potential of SHAP and Machine Learning for Personalized Explanations of Influencing Factors in Myopic Treatment for Children
title_short The Potential of SHAP and Machine Learning for Personalized Explanations of Influencing Factors in Myopic Treatment for Children
title_sort potential of shap and machine learning for personalized explanations of influencing factors in myopic treatment for children
topic myopia
atropine
intraocular pressure
machine learning
SHAP value
url https://www.mdpi.com/1648-9144/61/1/16
work_keys_str_mv AT junweichen thepotentialofshapandmachinelearningforpersonalizedexplanationsofinfluencingfactorsinmyopictreatmentforchildren
AT hsinanchen thepotentialofshapandmachinelearningforpersonalizedexplanationsofinfluencingfactorsinmyopictreatmentforchildren
AT tzuchiliu thepotentialofshapandmachinelearningforpersonalizedexplanationsofinfluencingfactorsinmyopictreatmentforchildren
AT tzuenwu thepotentialofshapandmachinelearningforpersonalizedexplanationsofinfluencingfactorsinmyopictreatmentforchildren
AT chijielu thepotentialofshapandmachinelearningforpersonalizedexplanationsofinfluencingfactorsinmyopictreatmentforchildren
AT junweichen potentialofshapandmachinelearningforpersonalizedexplanationsofinfluencingfactorsinmyopictreatmentforchildren
AT hsinanchen potentialofshapandmachinelearningforpersonalizedexplanationsofinfluencingfactorsinmyopictreatmentforchildren
AT tzuchiliu potentialofshapandmachinelearningforpersonalizedexplanationsofinfluencingfactorsinmyopictreatmentforchildren
AT tzuenwu potentialofshapandmachinelearningforpersonalizedexplanationsofinfluencingfactorsinmyopictreatmentforchildren
AT chijielu potentialofshapandmachinelearningforpersonalizedexplanationsofinfluencingfactorsinmyopictreatmentforchildren